71 related articles for article (PubMed ID: 16902117)
1. Microbiology. Breaking the barrier between commensalism and pathogenicity.
Hayashi T
Science; 2006 Aug; 313(5788):772-3. PubMed ID: 16902117
[No Abstract] [Full Text] [Related]
2. Escherichia coli induces DNA double-strand breaks in eukaryotic cells.
Nougayrède JP; Homburg S; Taieb F; Boury M; Brzuszkiewicz E; Gottschalk G; Buchrieser C; Hacker J; Dobrindt U; Oswald E
Science; 2006 Aug; 313(5788):848-51. PubMed ID: 16902142
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli ClbS is a colibactin resistance protein.
Bossuet-Greif N; Dubois D; Petit C; Tronnet S; Martin P; Bonnet R; Oswald E; Nougayrède JP
Mol Microbiol; 2016 Mar; 99(5):897-908. PubMed ID: 26560421
[TBL] [Abstract][Full Text] [Related]
4. Enteroaggregative Escherichia coli an emergent pathogen with different virulence properties.
Villaseca JM; Hernández U; Sainz-Espuñes TR; Rosario C; Eslava C
Rev Latinoam Microbiol; 2005; 47(3-4):140-59. PubMed ID: 17061538
[TBL] [Abstract][Full Text] [Related]
5. New genotoxin shows diversity of bacterial attack mechanisms.
Lax AJ
Trends Mol Med; 2007 Mar; 13(3):91-3. PubMed ID: 17234453
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island.
Nowrouzian FL; Oswald E
Microb Pathog; 2012 Sep; 53(3-4):180-2. PubMed ID: 22709536
[TBL] [Abstract][Full Text] [Related]
7. Commensal bacteria do translocate across the intestinal barrier in surgical patients.
Reddy BS; MacFie J; Gatt M; Macfarlane-Smith L; Bitzopoulou K; Snelling AM
Clin Nutr; 2007 Apr; 26(2):208-15. PubMed ID: 17208338
[TBL] [Abstract][Full Text] [Related]
8. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains.
Le Gall T; Clermont O; Gouriou S; Picard B; Nassif X; Denamur E; Tenaillon O
Mol Biol Evol; 2007 Nov; 24(11):2373-84. PubMed ID: 17709333
[TBL] [Abstract][Full Text] [Related]
9. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
[TBL] [Abstract][Full Text] [Related]
10. An adherent mucus layer attenuates the genotoxic effect of colibactin.
Reuter C; Alzheimer M; Walles H; Oelschlaeger TA
Cell Microbiol; 2018 Feb; 20(2):. PubMed ID: 29156489
[TBL] [Abstract][Full Text] [Related]
11. Improved catalytic activity of a purified multienzyme from a modular polyketide synthase after coexpression with Streptomyces chaperonins in Escherichia coli.
Betancor L; Fernández MJ; Weissman KJ; Leadlay PF
Chembiochem; 2008 Dec; 9(18):2962-6. PubMed ID: 19021139
[No Abstract] [Full Text] [Related]
12. Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater.
Sabaté M; Prats G; Moreno E; Ballesté E; Blanch AR; Andreu A
Res Microbiol; 2008 May; 159(4):288-93. PubMed ID: 18434099
[TBL] [Abstract][Full Text] [Related]
13. Rational design and assembly of synthetic trimodular polyketide synthases.
Menzella HG; Carney JR; Santi DV
Chem Biol; 2007 Feb; 14(2):143-51. PubMed ID: 17317568
[TBL] [Abstract][Full Text] [Related]
14. Determination of the extent of phosphopantetheinylation of polyketide synthases expressed in Escherichia coli and Saccharomyces cerevisiae.
Lee KK; Da Silva NA; Kealey JT
Anal Biochem; 2009 Nov; 394(1):75-80. PubMed ID: 19595983
[TBL] [Abstract][Full Text] [Related]
15. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
Bielaszewska M; Zhang W; Mellmann A; Karch H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):279-87. PubMed ID: 17715820
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of AIDA-I receptors in porcine intestinal mucus.
Fang Y; Ngeleka M; Middleton DM; Simko E
Vet Microbiol; 2008 Jan; 126(4):345-55. PubMed ID: 17764859
[TBL] [Abstract][Full Text] [Related]
17. Novel model to study virulence determinants of Escherichia coli K1.
Khan NA; Goldsworthy GJ
Infect Immun; 2007 Dec; 75(12):5735-9. PubMed ID: 17875634
[TBL] [Abstract][Full Text] [Related]
18. Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
Starcic Erjavec M; Rijavec M; Krizan-Hergouth V; Fruth A; Zgur-Bertok D
Int J Antimicrob Agents; 2007 Nov; 30(5):436-42. PubMed ID: 17719751
[TBL] [Abstract][Full Text] [Related]
19. Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota.
Eaton K; Yang W;
Elife; 2015 Mar; 4():. PubMed ID: 25781343
[TBL] [Abstract][Full Text] [Related]
20. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates.
Houdouin V; Bonacorsi S; Bidet P; Bingen-Bidois M; Barraud D; Bingen E
J Antimicrob Chemother; 2006 Oct; 58(4):748-51. PubMed ID: 16905527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
